GLENMARK PHARMACEUTICALS LIMITED

Active    As on: 14 August, 2022    Update Info    Print    Share

OVERVIEW - GLENMARK PHARMACEUTICALS LIMITED

Glenmark Pharmaceuticals Limited is a listed public company incorporated on 18 November, 1977. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 277.00 cr and the total paid-up capital is INR 28.22 cr.

Glenmark Pharmaceuticals Limited's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2021. It's EBITDA has increased by 44.94 % over the previous year. At the same time, it's book networth has increased by 11.97 %. Other performance and liquidity ratios are available here.

Description: The company develops, manufactures, and markets pharmaceutical products in India, the United States, Latin America, Europe, and internationally. The company provides branded and generic formulations in therapeutic areas of dermatology, respiratory, and oncology.

Products & Services: GBR 1302 for breast and gastric cancer; GBR 1342 for multiple myeloma; GBR 1372 for colorectal cancer; GBR 830 for atopic dermatitis; GRC 39815 for COPD and IPF; Ryaltris for allergic rhinitis; GSP 304 for COPD; GBR 310 for Asthma and CIU; and GRC 27864 for chronic pain indications
Category: Manufacturer

The current status of Glenmark Pharmaceuticals Limited is - Active.

The last reported AGM (Annual General Meeting) of Glenmark Pharmaceuticals Limited, per our records, was held on 24 September, 2021. Also, as per our records, its last balance sheet was prepared for the period ending on 31 March, 2021.

Glenmark Pharmaceuticals Limited has 11 directors - Blanche Saldanha Elizabeth, Rajesh Vasudeo Desai, and others.

The Corporate Identification Number (CIN) of Glenmark Pharmaceuticals Limited is L24299MH1977PLC019982. The registered office of Glenmark Pharmaceuticals Limited is at B-2MAHALAXMI CHAMBERS22 BHULABHAI DESAI ROAD, MAHALAXMI, MUMBAI, Maharashtra.

The Modern SME TOFLER
The right logistics partner for your business

A good logistics partner is the backbone of D2C businesses. It affects your customer experience, brand image, delivery economics and more. Mr. Nayan Ratandhyara, CEO & founder of Shipyaari delves into economics of delivery, working capital challenge, delivery risks and important things that you should consider when choosing a logistics partner for your D2C businesses.

Watch full video
  • COMPANY FINANCIALS
  • INR 349/-
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349/-
    All financials and shareholder returns filed with MCA since year 2006 upto 31 March, 2021 along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249/-
    Balance Sheet, Profit and Loss# and shareholder return for 31 March, 2021 along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799/-
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2021. However, in case, they are not yet filed with MCA, then last filed financials shall be provided instead.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about the businesses you deal with. About your vendors, clients and competitors.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest newsletters:

Best ways for entrepreneurs to manage money

Realistic Ways To Fund Your Startup

REGISTERED DETAILS - GLENMARK PHARMACEUTICALS LIMITED


CIN

L24299MH1977PLC019982

Incorporation Date / Age

18 November, 1977 / 45 yrs

Last Reported AGM Date

24 September, 2021

Authorized Capital

INR 27700.0 Lacs

Paidup Capital

INR 2821.68156 Lacs

industry*

Manufacturing (Chemicals and chemical products)

type

Listed Public Company

category

Company limited by Shares

subcategory

Non-govt company

Email Address

Login for email address. This is to prevent spam.

Website

http://www.glenmarkpharma.com. (Incorrect website?)

Registered Address

B-2MAHALAXMI CHAMBERS22 BHULABHAI DESAI ROAD
MAHALAXMI
MUMBAI - 400026
Maharashtra - India

How to download GLENMARK PHARMACEUTICALS LIMITED report

A Company report by Tofler is an easy-to-read PDF report that includes company's financial information, ratio analysis, management, group structure, shareholding pattern and more. Such reports can be bought from company pages at Tofler (Sample) or can be downloaded from Company360. Here is the video showing how a report downloaded from Company360 looks like.

GLENMARK PHARMACEUTICALS LIMITED - Registration Details
CINL24299MH1977PLC019982
Incorporation Date / Age18 November, 1977 / 45 yrs
Last Reported AGM Date24 September, 2021
Authorized CapitalINR 27700.0 Lacs
Paidup CapitalINR 2821.68156 Lacs
industry*Manufacturing (Chemicals and chemical products)
typeListed Public Company
categoryCompany limited by Shares
subcategoryNon-govt company
Email Address
Websitehttp://www.glenmarkpharma.com
Registered AddressB-2MAHALAXMI CHAMBERS22 BHULABHAI DESAI ROAD MAHALAXMI MUMBAI - 400026 Maharashtra - India

FINANCIAL HIGHLIGHTS - GLENMARK PHARMACEUTICALS LIMITED

Provided here are the financial indicators for financial year ending on 31 March, 2021. Actual numbers and more financial data, updated until 31 March, 2021* are included in purchased financial report.
View Sample Report.
Operating Revenue Over INR 500 cr
EBITDA 44.94 %
Networth 11.97 %
Debt/Equity Ratio 0.24
Return on Equity 11.14 %
See more...

* Company has reported to have approved financials for 31 March, 2021. However, in case, they are not yet filed with MCA, then last filed financials shall be provided instead.
How to get financial reports of GLENMARK PHARMACEUTICALS LIMITED

Tofler Company360 provides access to any Indian company's financial documents, charts, ratio analysis and more. It lets you compare financials of several companies and study performance trends. These financials can also be downloaded in excel format. Here is the video showing how you can study the financials of an Indian company on the Company360 platform.

Directors - GLENMARK PHARMACEUTICALS LIMITED

The company has 11 directors and 2 reported key management personnel.


The longest serving director currently on board is Glenn Mario Saldanha who was appointed on 12 October, 1998. Glenn Mario Saldanha has been on the board for more than 23 years. The most recently appointed director is Dipankar Bhattacharjee, who was appointed on 14 August, 2020.


Devendra Raj Mehta has the largest number of other directorships with a seat at a total of 10 companies. In total, the company is connected to 18 other companies through its directors.


NAME DESIGNATION APPOINTMENT DATE
BLANCHE SALDANHA ELIZABETH Director 14 August, 2009 Other directorships - GM PHARMA LIMITED,  GLENMARK ACCESS LIMITED, 
RAJESH VASUDEO DESAI Director 16 May, 2002 Other directorships - DESVEN CONSULTANTS PRIVATE LIMITED,  GLENMARK GENERICS LIMITED, 
SRIDHAR GORTHI Director 26 April, 2005 Other directorships - GLENMARK LIFE SCIENCES LIMITED,  KSHNA CAPITAL ADVISORS LLP,  SCOTTISH AND NEWCASTLE INDIA PRIVATE LIM ITED,  AUROUS COMMUNICATIONS AND EVENTS INDIA PRIVATE LIMITED,  GLENMARK GENERICS LIMITED,  PIRAMAL PHARMA LIMITED,  HATHWAY CABLE AND DATACOM LIMITED, 
GLENN MARIO SALDANHA Director 12 October, 1998 Other directorships - GLENMARK LIFE SCIENCES LIMITED,  GM PHARMA LIMITED,  GLENMARK ACCESS LIMITED,  GLENMARK GENERICS LIMITED, 
BRIAN WILLIAM TEMPEST Director 30 January, 2012 No other directorships
CHERYLANN MARIA PINTO Director 16 May, 2007 Other directorships - GLENMARK ACCESS LIMITED, 
DEVENDRA RAJ MEHTA Director 14 August, 2009 Other directorships - ASHRAY HOMES BUILDWELL PRIVATE LIMITED,  ATUL RAJASTHAN DATE PALMS LIMITED,  BAIF INSTITUTE FOR SUSTAINABLE LIVELIHOODS AND DEVELOPMENT,  GANDHI RESEARCH FOUNDATION,  GLENMARK GENERICS LIMITED,  MM AUTO INDUSTRIES LIMITED,  JAIN IRRIGATION SYSTEMS LIMITED,  JMC PROJECTS (INDIA) LIMITED,  POLY MEDICURE LIMITED, 
V S MANI KMP 16 November, 2017 No other directorships
V S MANI Director 29 May, 2018 Other directorships - GLENMARK LIFE SCIENCES LIMITED, 
BERNARD HUBERT MUNOS Director 30 January, 2012 No other directorships
SONA SAIRA RAMASASTRY Director 01 April, 2019 No other directorships
DIPANKAR BHATTACHARJEE Director 14 August, 2020 No other directorships
HARISH VINAYAK KUBER KMP 02 February, 2017 No other directorships
NAME DESIGNATION APPOINTMENT DATE
BLANCHE SALDANHA ELIZABETH Director 14 August, 2009 View other directorships
RAJESH VASUDEO DESAI Director 16 May, 2002 View other directorships
SRIDHAR GORTHI Director 26 April, 2005 View other directorships
GLENN MARIO SALDANHA Director 12 October, 1998 View other directorships
BRIAN WILLIAM TEMPEST Director 30 January, 2012 No other directorships
CHERYLANN MARIA PINTO Director 16 May, 2007 View other directorships
DEVENDRA RAJ MEHTA Director 14 August, 2009 View other directorships
V S MANI KMP 16 November, 2017 No other directorships
V S MANI Director 29 May, 2018 View other directorships
BERNARD HUBERT MUNOS Director 30 January, 2012 No other directorships
SONA SAIRA RAMASASTRY Director 01 April, 2019 No other directorships
DIPANKAR BHATTACHARJEE Director 14 August, 2020 No other directorships
HARISH VINAYAK KUBER KMP 02 February, 2017 No other directorships
12 October, 1998

GLENN MARIO SALDANHA

Director

16 May, 2002

RAJESH VASUDEO DESAI

Director

26 April, 2005

SRIDHAR GORTHI

Director

16 May, 2007

CHERYLANN MARIA PINTO

Director

14 August, 2009

BLANCHE SALDANHA ELIZABETH

Director

14 August, 2009

DEVENDRA RAJ MEHTA

Director

30 January, 2012

BRIAN WILLIAM TEMPEST

Director

30 January, 2012

BERNARD HUBERT MUNOS

Director

02 February, 2017

HARISH VINAYAK KUBER

KMP

16 November, 2017

V S MANI

KMP

29 May, 2018

V S MANI

Director

01 April, 2019

SONA SAIRA RAMASASTRY

Director

14 August, 2020

DIPANKAR BHATTACHARJEE

Director

Previous Directors - GLENMARK PHARMACEUTICALS LIMITED

Login to view previous directors

Bank-wise Biggest Charges on Assets

See more...

Previous Names

No previous names were found for this company.

Previous CINs

No previous CINs were found for this company.

SIMILAR COMPANIES

NAME INCORPORATION YEAR STATE PAID UP CAPITAL
MANEESH PHARMACEUTICALS LIMITED It was formed in year 1985 in Maharashtra . The company currently has a paid up capital of INR 28.13 cr.
1985 Maharashtra 28.13 cr Buy financial reports
LUBRIZOL MANUFACTURING INDIA PRIVATE LIMITED It was formed in year 2020 in Maharashtra . The company currently has a paid up capital of INR 28.00 cr.
2020 Maharashtra 28.00 cr Buy financial reports
AEGAN BATTERIES LIMITED It was formed in year 2010 in Karnataka . The company currently has a paid up capital of INR 28.00 cr.
2010 Karnataka 28.00 cr Buy financial reports
ADCOCK INGRAM PHARMA PRIVATE LIMITED It was formed in year 2021 in Karnataka . The company currently has a paid up capital of INR 28.00 cr.
2021 Karnataka 28.00 cr Buy financial reports
SIRIS LIMITED It was formed in year 1966 in Andhra Pradesh . The company currently has a paid up capital of INR 28.00 cr.
1966 Andhra Pradesh 28.00 cr Buy financial reports
VOVANTIS LABORATORIES PRIVATE LIMITED It was formed in year 2008 in Gujarat . The company currently has a paid up capital of INR 28.50 cr.
2008 Gujarat 28.50 cr Buy financial reports
MOMENTIVE PERFORMANCE MATERIALS (INDIA) PRIVATE LIMITED It was formed in year 1995 in Karnataka . The company currently has a paid up capital of INR 28.63 cr.
1995 Karnataka 28.63 cr Buy financial reports
SOFTGEL HEALTHCARE PRIVATE LIMITED It was formed in year 2003 in Tamil Nadu . The company currently has a paid up capital of INR 27.77 cr.
2003 Tamil Nadu 27.77 cr Buy financial reports
LYKA LABS LIMITED It was formed in year 1976 in Gujarat . The company currently has a paid up capital of INR 28.69 cr.
1976 Gujarat 28.69 cr Buy financial reports
HUMAN BIOSCIENCES INDIA LIMITED It was formed in year 2000 in Delhi . The company currently has a paid up capital of INR 28.72 cr.
2000 Delhi 28.72 cr Buy financial reports

SUBSIDIARY COMPANIES

No Indian subsidiary companies found.

Company Network - GLENMARK PHARMACEUTICALS LIMITED

Company Network • Tofler Business Research Platform
How to use company network of GLENMARK PHARMACEUTICALS LIMITED

Tofler Company network is a powerful feature that allows you to explore and discover common directorships between companies. It helps you find out other directorships of an Indian director and where else he has business interests. The feature is available for unlimited use in Company360 platform. Here is the video showing how you can explore company networks to discover hidden relationships between companies.

About - GLENMARK PHARMACEUTICALS LIMITED Edit

Add Company Info • Tofler Business Research Platform

FAQ - GLENMARK PHARMACEUTICALS LIMITED

  • What is the Incorporation date of GLENMARK PHARMACEUTICALS LIMITED?

    The Incorporation Date of GLENMARK PHARMACEUTICALS LIMITED is 18 November, 1977.

  • What is the operating revenue of GLENMARK PHARMACEUTICALS LIMITED?

    The operating revenue of GLENMARK PHARMACEUTICALS LIMITED is in the range of Over INR 500 cr for the financial year ending on 31 March, 2021.

  • What is the change in EBITDA of GLENMARK PHARMACEUTICALS LIMITED since last year?

    The EBITDA of GLENMARK PHARMACEUTICALS LIMITED has increased by 44.94 % over the previous year. At the same time, it's book networth has increased by 11.97 % for the financial year ending 31 March, 2021.

  • What is the business of GLENMARK PHARMACEUTICALS LIMITED?

    The company develops, manufactures, and markets pharmaceutical products in India, the United States, Latin America, Europe, and internationally. The company provides branded and generic formulations in therapeutic areas of dermatology, respiratory, and oncology..

  • Which Products and Services are provided by GLENMARK PHARMACEUTICALS LIMITED?

    The products and services offered by GLENMARK PHARMACEUTICALS LIMITED are GBR 1302 for breast and gastric cancer; GBR 1342 for multiple myeloma; GBR 1372 for colorectal cancer; GBR 830 for atopic dermatitis; GRC 39815 for COPD and IPF; Ryaltris for allergic rhinitis; GSP 304 for COPD; GBR 310 for Asthma and CIU; and GRC 27864 for chronic pain indications.

  • Who are the directors of GLENMARK PHARMACEUTICALS LIMITED?

    Glenmark Pharmaceuticals Limited has 11 directors - Blanche Saldanha Elizabeth, Rajesh Vasudeo Desai, and others.

  • COMPANY FINANCIALS
  • INR 349/-
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349/-
    All financials and shareholder returns filed with MCA since year 2006 upto 31 March, 2021 along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249/-
    Balance Sheet, Profit and Loss# and shareholder return for 31 March, 2021 along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799/-
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2021. However, in case, they are not yet filed with MCA, then last filed financials shall be provided instead.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about the businesses you deal with. About your vendors, clients and competitors.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest newsletters:

Best ways for entrepreneurs to manage money

Realistic Ways To Fund Your Startup




Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More